RANI Rani Therapeutics Holdings, Inc.: Operating Sales Margin

Public company logo of Rani Therapeutics (RANI)

Scaling alliances with pharma behemoths to implement oral delivery systems will create a foundation for long-term growth, as confirmed by the operating margin metric; the value -530.40 captures this indicator. The potential of Rani Therapeutics (RANI) is based on the high-margin RaniPill robotic capsules with low production costs. This technology replaces biologic injections with a microinjection into the intestine, opening access to a massive drug market.

RANI - Rani Therapeutics Holdings Operating Profit Ratio over the range 07/04/2022 - 11/20/2026

Metric breakdowns and analytics for Rani Therapeutics Inc (RANI)

- share price and consensus valuation forecast:
Fundamental company valuation:ranitherapeutics.com, RANI
Finished products of Rani Therapeutics Holdings

Operating margin reflects the share of profit from core operations in total revenue, demonstrating the business's ability to generate income before accounting for taxes and the cost of debt. By analyzing operating margin trends, an investor assesses the efficiency of R&D expenditures at Rani Therapeutics (RANI), where negative values confirm intensive cash burn to develop the injectable capsule platform and pursue strategic partnerships.

Main competitors

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|CPIX: Operating Margin|Quantum BioPharma Ltd. - Operating Profit Rate|FGEN (FibroGen Corp) - Operating Margin|Telomir Pharma (TELO) - Profitability of Operations|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.